Indoco Remedies shares rallied over 13% on Wednesday, 18 November, even as the broader stock market remained subdued. The pharmaceutical stock has gained 13.21% over the past week and 16.25% over the past two weeks, extending its recent recovery.
The stock opened at an intraday low of ₹226.75 apiece before climbing to a high of ₹254.75 during the session.
The sharp rally has brought the stock into focus, with technical experts pointing to improving momentum, strong volumes and crucial resistance levels that could determine its next move.
Sudeep Shah, Head of Technical and Derivatives Research at SBI Securities, said the stock has rebounded nearly 24% from its low of ₹205.10 in just 14 trading sessions. Following the recovery, it has moved above its key moving averages, signalling an improvement in near-term momentum.
However, Shah cautioned that the broader trend remains range-bound, with the stock having consolidated within the ₹205–288 range over the past few months.